There is a reduction in the level of SLC1A2 mRNA, which encodes the astrocyte-enriched glutamate transporter GLT1/EAAT2 in postmortem HD patient striatal tissues (Arzberger et al., 1997), implicating astrocytes in excitotoxicity in HD. Here, SLC1A2 is linked to Huntington disease.